Barely Significant
← all excerpts

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.

BMJ Open Diabetes Res Care · 2022 · PMC8783825 · PMID 35058313

3
hedged sentences
closest p
boldest claim

The sentences

nominally significantno p-value reported
Given the exploratory nature of our study and the large number of models for the 6 outcomes and 11 plasma AGEs and oxidation markers, no adjustment for multiplicity was performed, and associations with p values <0.05 were considered nominally significant.

also in 7,732 other papers

borderline significantno p-value reported
However, these associations did not remain significant after adjustment for spot HbA1c, that is, HbA1c closest to TP1, although the MetSOX association that was borderline significant with kidney disease now became significant.

also in 11,409 other papers

highly significantno p-value reported
These data are similar (or consistent with) the results of the skin biopsies formerly obtained with only ~200 DCCT participants showing that the long-term risk of complications was highly significant for retinopathy with FL (furosine) and GSPN, kidney disease with FL/GSPN and neuropathy with FL/MG-H1 despite all adjustments.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.